Encompass Health Corporation Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest
Encompass Health Corporation (EHC) reported Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest of $50.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest · last filed 2026-08-07
- Encompass Health Corporation net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $50.40M, a 23.53% increase year-over-year.
- Encompass Health Corporation net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was $51.00M, a 19.72% increase year-over-year.
- Encompass Health Corporation net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2025-12-31 was $53.90M, a 27.12% increase year-over-year.
- Encompass Health Corporation net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was $46.20M, a 22.55% increase year-over-year.
- Encompass Health Corporation net income (loss) attributable to nonredeemable noncontrolling interest for fiscal 2025 was $183.50M, a 35.13% increase from fiscal 2024.
- Encompass Health Corporation net income (loss) attributable to nonredeemable noncontrolling interest for fiscal 2024 was $135.80M, a 32.23% increase from fiscal 2023.
- Encompass Health Corporation net income (loss) attributable to nonredeemable noncontrolling interest for fiscal 2023 was $102.70M, a 17.10% increase from fiscal 2022.
- Encompass Health Corporation net income (loss) attributable to nonredeemable noncontrolling interest for fiscal 2022 was $87.70M, a 8.65% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.40M 10-Q · filed 2026-08-07 | $101.40M 10-Q · filed 2026-08-07 | $155.30M derived: sum of 3 quarters · filed 2026-08-07 | $201.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $51.00M 10-Q · filed 2026-05-01 | $104.90M derived: sum of 2 quarters · filed 2026-05-01 | $151.10M derived: sum of 3 quarters · filed 2026-05-01 | $191.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $53.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $100.10M derived: sum of 2 quarters · filed 2026-02-26 | $140.90M derived: sum of 3 quarters · filed 2026-08-07 | $183.50M 10-K · filed 2026-02-26 |
| 2025-09-30 | $46.20M 10-Q · filed 2025-10-31 | $87.00M derived: sum of 2 quarters · filed 2026-08-07 | $129.60M 10-Q · filed 2025-10-31 | $172.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $40.80M 10-Q · filed 2026-08-07 | $83.40M 10-Q · filed 2026-08-07 | $125.80M derived: sum of 3 quarters · filed 2026-08-07 | $163.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $42.60M 10-Q · filed 2026-05-01 | $85.00M derived: sum of 2 quarters · filed 2026-05-01 | $122.70M derived: sum of 3 quarters · filed 2026-05-01 | $153.60M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $42.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $80.10M derived: sum of 2 quarters · filed 2026-02-26 | $111.00M derived: sum of 3 quarters · filed 2026-02-26 | $135.80M 10-K · filed 2026-02-26 |
| 2024-09-30 | $37.70M 10-Q · filed 2025-10-31 | $68.60M derived: sum of 2 quarters · filed 2025-10-31 | $93.40M 10-Q · filed 2025-10-31 | $122.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $30.90M 10-Q · filed 2025-08-06 | $55.70M 10-Q · filed 2025-08-06 | $85.10M derived: sum of 3 quarters · filed 2026-02-26 | $111.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $24.80M 10-Q · filed 2025-05-01 | $54.20M derived: sum of 2 quarters · filed 2026-02-26 | $80.40M derived: sum of 3 quarters · filed 2026-02-26 | $104.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $29.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $55.60M derived: sum of 2 quarters · filed 2026-02-26 | $79.20M derived: sum of 3 quarters · filed 2026-02-26 | $102.70M 10-K · filed 2026-02-26 |
| 2023-09-30 | $26.20M 10-Q · filed 2024-11-01 | $49.80M derived: sum of 2 quarters · filed 2024-11-01 | $73.30M 10-Q · filed 2024-11-01 | $99.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $23.60M 10-Q · filed 2024-08-06 | $47.10M 10-Q · filed 2024-08-06 | $73.00M derived: sum of 3 quarters · filed 2025-02-28 | $93.00M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $23.50M 10-Q · filed 2024-05-02 | $49.40M derived: sum of 2 quarters · filed 2025-02-28 | $69.40M derived: sum of 3 quarters · filed 2025-02-28 | $90.50M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $25.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $45.90M derived: sum of 2 quarters · filed 2025-02-28 | $67.00M derived: sum of 3 quarters · filed 2025-02-28 | $87.70M 10-K · filed 2025-02-28 |
| 2022-09-30 | $20.00M 10-Q · filed 2023-11-01 | $41.10M derived: sum of 2 quarters · filed 2023-11-01 | $61.80M 10-Q · filed 2023-11-01 | $84.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $21.10M 10-Q · filed 2023-08-04 | $41.80M 10-Q · filed 2023-08-04 | $64.20M derived: sum of 3 quarters · filed 2024-02-28 | $88.70M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $20.70M 10-Q · filed 2023-05-03 | $43.10M derived: sum of 2 quarters · filed 2024-02-28 | $67.60M derived: sum of 3 quarters · filed 2024-02-28 | $93.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $22.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $46.90M derived: sum of 2 quarters · filed 2024-02-28 | $72.90M derived: sum of 3 quarters · filed 2024-02-28 | $96.00M 10-K · filed 2024-02-28 |
| 2021-09-30 | $24.50M 10-Q · filed 2022-11-02 | $50.50M derived: sum of 2 quarters · filed 2022-11-02 | $73.60M 10-Q · filed 2022-11-02 | $97.60M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $26.00M 10-Q · filed 2022-08-04 | $49.10M 10-Q · filed 2022-08-04 | $73.10M derived: sum of 3 quarters · filed 2023-02-27 | $93.30M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $23.10M 10-Q · filed 2022-05-03 | $47.10M derived: sum of 2 quarters · filed 2023-02-27 | $67.30M derived: sum of 3 quarters · filed 2023-02-27 | $80.60M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $44.20M derived: sum of 2 quarters · filed 2023-02-27 | $57.50M derived: sum of 3 quarters · filed 2023-02-27 | $77.20M 10-K · filed 2023-02-27 |
| 2020-09-30 | $20.20M 10-Q · filed 2021-11-02 | $33.50M derived: sum of 2 quarters · filed 2021-11-02 | $53.20M 10-Q · filed 2021-11-02 | $73.30M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $13.30M 10-Q · filed 2021-08-03 | $33.00M 10-Q · filed 2021-08-03 | $53.10M derived: sum of 3 quarters · filed 2022-02-25 | $71.30M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $19.70M 10-Q · filed 2021-05-04 | $39.80M derived: sum of 2 quarters · filed 2022-02-25 | $58.00M derived: sum of 3 quarters · filed 2022-02-25 | $75.30M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $20.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $38.30M derived: sum of 2 quarters · filed 2022-02-25 | $55.60M derived: sum of 3 quarters · filed 2022-02-25 | $74.50M 10-K · filed 2022-02-25 |
| 2019-09-30 | $18.20M 10-Q · filed 2020-11-02 | $35.50M derived: sum of 2 quarters · filed 2020-11-02 | $54.40M 10-Q · filed 2020-11-02 | $70.40M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $17.30M 10-Q · filed 2020-07-31 | $36.20M 10-Q · filed 2020-07-31 | $52.20M derived: sum of 3 quarters · filed 2021-02-26 | $69.10M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $18.90M 10-Q · filed 2020-05-11 | $34.90M derived: sum of 2 quarters · filed 2021-02-26 | $51.80M derived: sum of 3 quarters · filed 2021-02-26 | $69.50M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $32.90M derived: sum of 2 quarters · filed 2021-02-26 | $50.60M derived: sum of 3 quarters · filed 2021-02-26 | $69.20M 10-K · filed 2021-02-26 |
| 2018-09-30 | $16.90M 10-Q · filed 2019-10-31 | $34.60M derived: sum of 2 quarters · filed 2019-10-31 | $53.20M 10-Q · filed 2019-10-31 | $71.10M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $17.70M 10-Q · filed 2019-07-31 | $36.30M 10-Q · filed 2019-07-31 | $54.20M derived: sum of 3 quarters · filed 2020-02-27 | $69.20M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $18.60M 10-Q · filed 2019-05-01 | $36.50M derived: sum of 2 quarters · filed 2020-02-27 | $51.50M derived: sum of 3 quarters · filed 2020-02-27 | $65.30M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $17.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $32.90M derived: sum of 2 quarters · filed 2020-02-27 | $46.70M derived: sum of 3 quarters · filed 2020-02-27 | $61.20M 10-K · filed 2020-02-27 |
| 2017-09-30 | $15.00M 10-Q · filed 2018-10-31 | $28.80M derived: sum of 2 quarters · filed 2018-10-31 | $43.30M 10-Q · filed 2018-10-31 | $57.20M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $13.80M 10-Q · filed 2018-08-02 | $28.30M 10-Q · filed 2018-08-02 | $42.20M derived: sum of 3 quarters · filed 2019-02-27 | $54.90M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $14.50M 10-Q · filed 2018-05-02 | $28.40M derived: sum of 2 quarters · filed 2019-02-27 | $41.10M derived: sum of 3 quarters · filed 2019-02-27 | $56.10M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $26.60M derived: sum of 2 quarters · filed 2019-02-27 | $41.60M derived: sum of 3 quarters · filed 2019-02-27 | $56.40M 10-K · filed 2019-02-27 |
| 2016-09-30 | $12.70M 10-Q · filed 2017-10-31 | $27.70M derived: sum of 2 quarters · filed 2017-10-31 | $42.50M 10-Q · filed 2017-10-31 | $57.60M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $15.00M 10-Q · filed 2017-08-02 | $29.80M 10-Q · filed 2017-08-02 | $44.90M derived: sum of 3 quarters · filed 2018-02-28 | $58.30M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $14.80M 10-Q · filed 2017-04-28 | $29.90M derived: sum of 2 quarters · filed 2018-02-28 | $43.30M derived: sum of 3 quarters · filed 2018-02-28 | $57.10M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $15.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $28.50M derived: sum of 2 quarters · filed 2018-02-28 | $42.30M derived: sum of 3 quarters · filed 2018-02-28 | $55.90M 10-K · filed 2018-02-28 |
| 2015-09-30 | $13.40M 10-Q · filed 2016-10-28 | $27.20M derived: sum of 2 quarters · filed 2016-10-28 | $40.80M 10-Q · filed 2016-10-28 | $55.00M derived: sum of 4 quarters · filed 2017-09-19 |
| 2015-06-30 | $13.80M 10-Q · filed 2016-07-29 | $27.40M 10-Q · filed 2016-07-29 | $41.60M derived: sum of 3 quarters · filed 2017-09-19 | $54.50M derived: sum of 4 quarters · filed 2017-09-19 |
| 2015-03-31 | $13.60M 10-Q · filed 2016-04-28 | $27.80M derived: sum of 2 quarters · filed 2017-09-19 | $40.70M derived: sum of 3 quarters · filed 2017-09-19 | $53.90M derived: sum of 4 quarters · filed 2017-09-19 |
| 2014-12-31 | $14.20M derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $27.10M derived: sum of 2 quarters · filed 2017-09-19 | $40.30M derived: sum of 3 quarters · filed 2017-09-19 | $53.10M 8-K · filed 2017-09-19 |
| 2014-09-30 | $12.90M 10-Q · filed 2015-10-29 | $26.10M derived: sum of 2 quarters · filed 2015-10-29 | $38.90M 10-Q · filed 2015-10-29 | $52.50M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $13.20M 10-Q · filed 2015-07-30 | $26.00M 10-Q · filed 2015-07-30 | $39.60M derived: sum of 3 quarters · filed 2016-02-25 | $52.20M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $12.80M 10-Q · filed 2015-05-01 | $26.40M derived: sum of 2 quarters · filed 2016-02-25 | $39.00M derived: sum of 3 quarters · filed 2016-02-25 | $51.50M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $13.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $26.20M derived: sum of 2 quarters · filed 2016-02-25 | $38.70M derived: sum of 3 quarters · filed 2016-02-25 | $52.00M 10-K · filed 2016-02-25 |
| 2013-09-30 | $12.60M 10-Q · filed 2014-10-28 | $25.10M derived: sum of 2 quarters · filed 2014-10-28 | $38.40M 10-Q · filed 2014-10-28 | $49.90M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $12.50M 10-Q · filed 2014-07-29 | $25.80M 10-Q · filed 2014-07-29 | $37.30M derived: sum of 3 quarters · filed 2015-03-02 | $49.00M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $13.30M 10-Q · filed 2014-04-29 | $24.80M derived: sum of 2 quarters · filed 2015-03-02 | $36.50M derived: sum of 3 quarters · filed 2015-03-02 | $48.80M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $23.20M derived: sum of 2 quarters · filed 2015-03-02 | $35.50M derived: sum of 3 quarters · filed 2015-03-02 | $47.10M 10-K · filed 2015-03-02 |
| 2012-09-30 | $11.70M 10-Q · filed 2013-10-29 | $24.00M derived: sum of 2 quarters · filed 2013-10-29 | $35.60M 10-Q · filed 2013-10-29 | |
| 2012-06-30 | $12.30M 10-Q · filed 2013-07-30 | $23.90M 10-Q · filed 2013-07-30 | ||
| 2012-03-31 | $11.60M 10-Q · filed 2013-04-26 | |||
| 2011-12-31 | $42.30M 10-K · filed 2014-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |